Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.4301
Delayed Data
As of Apr 21
 +0.0051 / +1.20%
Today’s Change
0.12
Today|||52-Week Range
0.50
+13.18%
Year-to-Date
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL
Apr 21 / Zacks.com - Paid Partner Content
After Johnson & Johnson Earnings, Buy These Pharma Stocks
Apr 18 / Zacks.com - Paid Partner Content
What to Expect From European Pharmaceuticals' First Quarter Results
Apr 21 / TheStreet.com - Paid Partner Content
Did Pharma & Biotech M&As Pick Pace in Q1?
Apr 18 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?
Apr 20 / Zacks.com - Paid Partner Content
5 Reasons Why Sanofi (SNY) is a Good Stock to Buy Now
Apr 12 / Zacks.com - Paid Partner Content
Sanofi Epilepsy Drug Responsible for Birth Defects in 4,100 Children, French Regulato...
Apr 20 / TheStreet.com - Paid Partner Content
Geron Stock Rises after Positive Interim Update on Imetelstat
Apr 11 / Zacks.com - Paid Partner Content
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Apr 19 / Zacks.com - Paid Partner Content
Forget Novartis, Buy These Two Pharma Stocks Instead
Apr 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close0.43
Today’s open0.42
Day’s range0.42 - 0.43
Volume42,921
Average volume (3 months)351,387
Market cap--
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs